Skip to content
drillr.ai
Sign up

TRAW

Traws Pharma, Inc.

NASDAQ · Healthcare · Biotechnology · US

$0.49
−8.50%
Ask drillr
0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-42.2%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Jul 16, 2026Pauza Charles David · officer: Chief Science Officer VirologyA-Award97,000$0.68
Jul 15, 2026Savchuk Nikolay · director, officer: Chief Operating OfficerA-Award93,000$0.68
Jul 15, 2026CAUTREELS WERNER · directorA-Award14,150$0.68
Jul 14, 2026STOVER JACK E · directorA-Award14,150$0.68
Jul 14, 2026Leaman John Harold · directorA-Award14,150$0.68
Jul 14, 2026Clarke Trafford · directorA-Award14,150$0.68
Jul 14, 2026Shoemaker Mary Teresa · directorA-Award14,150$0.68
Jul 14, 2026Parker Charles Nolan · officer: Chief Financial OfficerA-Award90,000$0.68
Jul 14, 2026Redfield Robert · officer: Chief Medical OfficerA-Award84,000$0.68
Jul 14, 2026Dukes Iain D. · director, officer: Chief Executive OfficerA-Award274,000$0.68
Apr 28, 2026ORBIMED ADVISORS LLC · 10 percent ownerPurchase597,729$1.67
Apr 28, 2026ORBIMED ADVISORS LLC · 10 percent ownerPurchase1,793,187$1.67
Apr 8, 2026Parker Charles Nolan · officer: Chief Financial OfficerA-Award104,544$1.60
Apr 8, 2026Parker Charles Nolan · officer: Chief Financial OfficerA-Award61,571$2.33
Apr 8, 2026Parker Charles Nolan · officer: Chief Financial OfficerA-Award32,406$3.01
Apr 8, 2026Parker Charles Nolan · officer: Chief Financial OfficerA-Award15,393$0.00
Mar 10, 2026CAUTREELS WERNER · directorA-Award31,258$1.60
Mar 10, 2026Clarke Trafford · directorA-Award33,435$1.60
Mar 10, 2026Redfield Robert · officer: Chief Medical OfficerA-Award108,854$1.60
Mar 10, 2026Shoemaker Mary Teresa · directorA-Award33,435$1.60
Mar 10, 2026STOVER JACK E · directorA-Award33,435$1.60
Mar 10, 2026Savchuk Nikolay · director, officer: Chief Operating OfficerA-Award96,899$1.60
Mar 10, 2026Pauza Charles David · officer: Chief Science Officer VirologyA-Award118,367$1.60
Mar 10, 2026Dukes Iain D. · director, officer: Chief Executive OfficerA-Award231,336$1.60
Mar 10, 2026Leaman John Harold · directorA-Award33,435$1.60
Dec 16, 2025Leaman John Harold · directorA-Award16,234$2.33
Dec 16, 2025Leaman John Harold · directorA-Award4,058$0.00
Dec 16, 2025Clarke Trafford · directorA-Award24,629$2.33
Dec 16, 2025Clarke Trafford · directorA-Award6,157$0.00
Dec 16, 2025CAUTREELS WERNER · directorA-Award4,874$0.00
Institutional positioning

13F filings over the trailing two quarters

New 27Increased 11Reduced 12Sold out 8
FilerActionSharesFiled
ORBIMED ADVISORS LLCIncreased1,203,260Aug 14, 2026
Ally Bridge Group (NY) LLCNew Position786,236Aug 14, 2026
ADAGE CAPITAL PARTNERS GP, L.L.C.Unchanged730,000May 15, 2026
ADAGE CAPITAL PARTNERS GP, L.L.C.Unchanged730,000Aug 14, 2026
IKARIAN CAPITAL, LLCUnchanged678,142May 15, 2026
ORBIMED ADVISORS LLCUnchanged605,531May 15, 2026
ADAR1 Capital Management, LLCIncreased597,729Aug 14, 2026
Lynx1 Capital Management LPIncreased559,470Aug 13, 2026
Squadron Capital Management LLCReduced511,714May 15, 2026
Ikarian Capital, LLCReduced478,142Aug 14, 2026
DAUNTLESS INVESTMENT GROUP, LLCNew Position416,998May 14, 2026
SPHERA FUNDS MANAGEMENT LTD.New Position398,486Aug 14, 2026
VANGUARD CAPITAL MANAGEMENT LLCIncreased330,049Aug 13, 2026
JANE STREET GROUP, LLCIncreased216,006Aug 14, 2026
BOOTHBAY FUND MANAGEMENT, LLCUnchanged194,536May 15, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jul 16, 2026